Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | S100A11 |
| Upstream (Parents) |
|---|
| (<<) S100A6 → S100A11 |
| (<<) CDCP1 → S100A11 |
| (<<) S100A11P1///S100A11 → S100A11 |
| (<<) FHL2 → S100A11 |
| (<<) S100A10 → S100A11 |
| (<<) LGALS3 → S100A11 |
| Downstream (Children) |
|---|
| S100A11 → TNFRSF12A (>>) |
| S100A11 → KLK10 (>>) |
| S100A11 → NBL1 (>>) |
| S100A11 → LAMC2 (>>) |
| S100A11 → CST6 (>>) |
| S100A11 → KLK11 (>>) |
| S100A11 → TREM2 (>>) |
| S100A11 → S100A6 (>>) |
| S100A11 → EPB41L1 (>>) |
| S100A11 → HBEGF (>>) |
| S100A11 → TNIP2 (>>) |
| S100A11 → FUT8 (>>) |
| S100A11 → SH3BGRL3 (>>) |
| S100A11 → SLC16A10 (>>) |
| S100A11 → FXYD5 (>>) |
| S100A11 → FOS (>>) |
| S100A11 → CAPG (>>) |
| S100A11 → SLC25A24 (>>) |
| S100A11 → IL2RG (>>) |
| S100A11 → S100A11P1///S100A11 (>>) |
| S100A11 → DGKA (>>) |
| S100A11 → FHL2 (>>) |
| S100A11 → PLAUR (>>) |
| S100A11 → S100A10 (>>) |
| S100A11 → MALL (>>) |
| S100A11 → PPP1R13L (>>) |
| S100A11 → SLC37A1 (>>) |
| S100A11 → SYK (>>) |
| S100A11 → CCRL2 (>>) |
| S100A11 → NUDT13 (>>) |
| S100A11 → SLC26A1 (>>) |
| S100A11 → GOLGA6L4///PML (>>) |
| S100A11 → TPM4 (>>) |
